Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer

被引：0
|
作者：
A. Matrone
A. Prete
A. Nervo
A. Ragni
L. Agate
E. Molinaro
C. Giani
L. Valerio
E. Minaldi
A. Piovesan
R. Elisei
机构：
[1] Pisa University Hospital,Department of Clinical and Experimental Medicine, Unit of Endocrinology
[2] Azienda Ospedaliero Universitaria Città Della Salute E Della Scienza Di Torino,Department of Oncology, Oncological Endocrinology Unit
来源：
Journal of Endocrinological Investigation | 2021年 / 44卷
关键词：
Lenvatinib; Medullary thyroid cancer; Calcitonin; Carcinoembrionic antigen; Tyrosine kinase inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2139 / 2151
页数：12
相关论文
共 50 条
  • [41] Diagnostic characteristics, treatment patterns, and clinical outcomes for patients with advanced/metastatic medullary thyroid cancer
    Rohan Parikh
    Lisa M. Hess
    Elizabeth Esterberg
    Naleen Raj Bhandari
    James A. Kaye
    Thyroid Research, 15
  • [42] Cabozantinib (XL184) for the treatment of locally advanced or metastatic progressive medullary thyroid cancer
    Viola, David
    Cappagli, Virginia
    Elisei, Rossella
    FUTURE ONCOLOGY, 2013, 9 (08) : 1083 - 1092
  • [43] Cabozantinib for progressive metastatic medullary thyroid cancer: a review
    Colombo, Joshua R.
    Wein, Richard O.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2014, 10 : 395 - 404
  • [44] Pretargeted radioimmunotherapy in the treatment of metastatic medullary thyroid cancer
    Kraeber-Bodere, F.
    Goldenberg, D. M.
    Chatal, J. F.
    Barbet, J.
    CURRENT ONCOLOGY, 2009, 16 (05) : 296 - 301
  • [45] Effect of sorafenib in symptomatic metastatic medullary thyroid cancer
    Kober, F.
    Hermann, M.
    Handler, A.
    Krotla, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [46] Cabozantinib for the treatment of progressive metastatic medullary thyroid cancer
    Krajewska, Jolanta
    Olczyk, Tomasz
    Jarzab, Barbara
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (01) : 69 - 79
  • [47] Exome sequencing of metastatic medullary thyroid cancer.
    Kelly, Deirdre
    Das, Sudipto
    Moran, Bruce
    Han, Kathleen
    Watson, Geoffrey Alan
    Harrold, Emily
    Gleeson, Jack
    O'Leary, Connor Gerard
    Prior, Lisa Mary
    Nugent, Killian
    Lim, Marvin Chang Jui
    Mulligan, Niall
    Carney, Desmond N.
    McCaffrey, John
    Kelly, Catherine Margaret
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [48] 2012 European Thyroid Association Guidelines for Metastatic Medullary Thyroid Cancer
    Schlumberger, M.
    Bastholt, L.
    Dralle, H.
    Jarzab, B.
    Pacini, F.
    Smit, J. W. A.
    EUROPEAN THYROID JOURNAL, 2012, 1 (01) : 5 - 14
  • [49] Histological findings of thyroid cancer after lenvatinib therapy
    Okubo, Yoichiro
    Toda, Soji
    Sato, Shinya
    Yoshioka, Emi
    Ono, Kyoko
    Hasegawa, Chie
    Washimi, Kota
    Yokose, Tomoyuki
    Miyagi, Yohei
    Iwasaki, Hiroyuki
    Hayashi, Hiroyuki
    HISTOPATHOLOGY, 2023, 83 (04) : 657 - 663
  • [50] Lenvatinib in thyroid cancer
    Kang, Seema
    LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (04): : 239 - 239
12345